[delta-Aminolevulinate dehydratase deficiency].
delta-Aminolevulinate dehydratase (ALAD: E. C. 4.2.1.24), the second enzyme in the heme biosynthetic pathway, condenses two moles of delta-aminolevulinic acid to form porphobilinogen. ALAD deficiency is well known to develop signs and symptoms of typical hepatic porphyria, and classified into three categories as follows: (i) ALAD porphyria, a genetic defect of the enzyme, (ii) tyrosinemia type I, a genetic defect of fumarylacetoacetase in the tyrosine catabolic pathway, producing succinylacetone (a potent inhibitor of ALAD), and (iii) ALAD inhibition by environmental hazards, such as lead, trichloroethylene, and styrene. In the present article, we will describe molecular and biochemical mechanisms to cause the enzyme defect to discuss the significance of ALAD defect on human health.
Fujita
H
H
Department of Applied Physiology and Molecular Biology, Tohoku University School of Medicine.
Ishida
N
N
Akagi
R
R
D001483:Base Sequence; D006801:Humans; D006867:Hydrolases / Q000172:deficiency; D007855:Lead Poisoning; D008969:Molecular Sequence Data; D009154:Mutation; D000623:Porphobilinogen Synthase / Q000172:deficiency* / Q000235:genetics; D017094:Porphyrias, Hepatic / Q000209:etiology
D006867:Hydrolases; C020156:fumarylacetoacetase; D000623:Porphobilinogen Synthase